KRAS and non-small cell lung carcinoma: The aim was to investigate the frequencies of EGFR, KRAS, BRAF, and HER-2 mutations in BM-NSCLC samples from 77 patients operated in the neurosurgery departments of Nice and Poitiers University Hospitals (France).